Morgan Stanley’s GP-Act III Acquisition Corp GPAT Stock Holding History

Morgan Stanley’s Portfolio GPAT Stock Details GPAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$250	Sell	23 -41	-64%	-$445	﹤0.01%	7821
2026 Q1	$694	Sell	64 -15	-19%	-$161	﹤0.01%	7540
2025 Q4	$845	Buy	79 +23	+41%	+$245	﹤0.01%	7406
2025 Q3	$594	Sell	56 -79	-59%	-$835	﹤0.01%	7468
2025 Q2	$1.42K	Buy	135 +103	+322%	+$1.08K	﹤0.01%	7290
2025 Q1	$329	Buy	+32	New	+$328	﹤0.01%	7420

Other funds holding GPAT

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

HIM

HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Morgan Stanley's GPAT Position: Q2 2026 in Review

Morgan Stanley reduced its GP-Act III Acquisition Corp (GPAT) stake by 64% in Q2 2026, selling an estimated $445 and leaving 23 shares worth $250. The position accounts for ﹤0.01% of the portfolio, ranked #7821.

Morgan Stanley first reported a position in GPAT in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.42K in Q2 2025. 24 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.

Morgan Stanley held 23 shares of GP-Act III Acquisition Corp worth $250 as of Q2 2026.
Morgan Stanley sold 41 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $445.
GP-Act III Acquisition Corp made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7821 holding.
Morgan Stanley first reported a position in GP-Act III Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
Morgan Stanley's GP-Act III Acquisition Corp position peaked at $1.42K in Q2 2025.
24 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.